Gynecologic oncology refers to the cancers of the female reproductive system, including ovarian cancer, uterine cancer, endometrial cancer, cervical cancer, and vulvar cancer. Gynecologic cancer is the fourth most common type of cancer in women, affecting approximately 1 in 20 women.

Regular screening is of utmost importance in the field of gynecologic oncology. By detecting specific cancers before any symptoms arise, these screenings can significantly reduce deaths and even prevent the development of the disease altogether. Given that gynecologic cancer is the fourth most common cancer among women, affecting approximately 1 in 20 individuals, early detection through screenings can make a substantial difference in improving outcomes for patients. However, it is important to note that screening methods vary depending on the type of gynecologic cancer being targeted. For example, pap smears and HPV tests are commonly used to screen for cervical cancer, while transvaginal ultrasounds and pelvic exams are more effective in detecting ovarian cancer. Women must consult with their healthcare providers to determine which screenings are appropriate for them based on their age, medical history, and other risk factors.

• Reduce the number of people who die from the disease, or prevent deaths from cancer altogether.
• Reduce the number of people who develop the disease.